Experience with Sorafenib in 3 Hospitals in Sao Paulo

Introduction and aim: Sorafenib has been the standard of care for first-line treatment of advanced hepatocellular carcinoma, a complex disease that affects an extremely heterogenous population. Thereby requiring multidisciplinary individualized treatment strategies that match the disease characteris...

Full description

Bibliographic Details
Main Authors: Rogério Camargo-Pinheiro-Alves, Daniele E. Viera-Alves, Arthur Malzyner, Otavio Gampel, Thaisa de F. Almeida-Costa, Betty Guz, Paula Poletti
Format: Article
Language:English
Published: Elsevier 2019-01-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119303199